Cargando…

Dietary supplement use and documentation in a breast cancer survivorship clinic

PURPOSE: Breast cancer survivors take vitamins and supplements to bolster their general health and to decrease the risk of cancer recurrence. Healthcare providers are frequently unaware of their patients non-prescription supplement use. The aim of this study was to study the type and the documentati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silver, Julia, Goldenberg, Alyson, Moore, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611172/ https://www.ncbi.nlm.nih.gov/pubmed/34817746 http://dx.doi.org/10.1007/s10549-021-06454-7

Ejemplares similares

Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival
por: Carmen, Albertini, et al.
Publicado: (2022)

The Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma
por: Himori, Noriko, et al.
Publicado: (2021)

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers
por: Obdeijn, Inge-Marie, et al.
Publicado: (2020)

Preventative therapy for breast cancer: a clinical experience
por: Law, Rebekah, et al.
Publicado: (2023)

The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
por: Collarino, Angela, et al.
Publicado: (2018)

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer
por: Inoue, Yuka, et al.
Publicado: (2022)

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation
por: Møller, Pål, et al.
Publicado: (2014)

Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance
por: Sanderink, W. B. G., et al.
Publicado: (2020)

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
por: de Pádua Souza, Cristiano, et al.
Publicado: (2023)

Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy
por: Pedersini, Rebecca, et al.
Publicado: (2023)

Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
por: Iwamoto, Takayuki, et al.
Publicado: (2016)

Awareness of link between obesity and breast cancer risk is associated with willingness to participate in weight loss intervention
por: Burkbauer, Laura, et al.
Publicado: (2022)

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
por: Pezo, Rossanna C., et al.
Publicado: (2017)

Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling
por: Gregory, Walter M., et al.
Publicado: (2016)

Chemotherapy use near the end-of-life in patients with metastatic breast cancer
por: Edman Kessler, Luisa, et al.
Publicado: (2020)

The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers
por: Anderson, Karen S., et al.
Publicado: (2022)

Essential Fatty Acid Supplementation and Early Inflammation in Preterm Infants: Secondary Analysis of a Randomized Clinical Trial
por: Wendel, Kristina, et al.
Publicado: (2023)

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial
por: Parker, Barbara A., et al.
Publicado: (2023)

Multiparametric radiomics methods for breast cancer tissue characterization using radiological imaging
por: Parekh, Vishwa S., et al.
Publicado: (2020)

Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer
por: Dixon, J. Michael, et al.
Publicado: (2020)

Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2021)

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
por: Drukker, C. A., et al.
Publicado: (2014)

Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life
por: Wyld, Lynda, et al.
Publicado: (2021)

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
por: Sachdev, Jasgit C., et al.
Publicado: (2020)

Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey
por: McGee, Sharon, et al.
Publicado: (2021)

Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials
por: Krois, Wilfried, et al.
Publicado: (2017)

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography
por: Møller, Pål, et al.
Publicado: (2015)

Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
por: Coe, Faye, et al.
Publicado: (2021)

Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety
por: Christenhusz, Anke, et al.
Publicado: (2023)

Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
por: Taylor, Caitlin, et al.
Publicado: (2023)

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer
por: Goncalves, Rodrigo, et al.
Publicado: (2017)

Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer
por: Liljegren, Annelie, et al.
Publicado: (2018)

Combining reconstructive and ablative surgical treatment of chronic breast cancer-related lymphedema (BCRL): safe and effective
por: Ghazaleh, Alina A., et al.
Publicado: (2022)

Risk of secondary malignancy after radiotherapy for breast cancer: long-term follow-up of Japanese patients with breast cancer
por: Okonogi, Noriyuki, et al.
Publicado: (2022)

Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer
por: Li, Huiping, et al.
Publicado: (2021)

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
por: Goorts, Briete, et al.
Publicado: (2017)

A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
por: Gunda, Aparna, et al.
Publicado: (2022)

High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2014)

Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands
por: Walstra, Coco J. E. F., et al.
Publicado: (2021)

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
por: van Hellemond, Irene E. G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1tsjsf4iv4a651nnjt6r1p5gia